Cancer Research

PTGES3 Emerges as Key Target in Prostate Cancer Treatment
Research & Development PTGES3 Emerges as Key Target in Prostate Cancer Treatment

In a significant leap forward for prostate cancer research, a recent study published in Nature Genetics on November 5 has spotlighted PTGES3 (Prostaglandin E Synthase 3) as a pivotal regulator of the androgen receptor (AR), a protein deeply implicated in the disease’s progression. Conducted by

Can Hidden Cell Structures Unlock New Leukemia Treatments?
Research & Development Can Hidden Cell Structures Unlock New Leukemia Treatments?

Leukemia, a relentless cancer affecting blood-forming cells, has puzzled researchers for decades due to its numerous genetic mutations that somehow result in strikingly similar disease outcomes in patients across diverse cases. A groundbreaking study from Baylor College of Medicine, recently

GLP-1 Drugs and Cancer: Risks and Protective Potential Unveiled
Research & Development GLP-1 Drugs and Cancer: Risks and Protective Potential Unveiled

In a world where obesity and type 2 diabetes affect millions, GLP-1 receptor agonists have emerged as transformative treatments, offering hope for better health outcomes. Yet, amidst their widespread adoption, a pressing concern lingers: could these powerful drugs, designed to regulate blood sugar

Colon Cancer and Shingles: Unveiling Risks and Prevention
Research & Development Colon Cancer and Shingles: Unveiling Risks and Prevention

In a world where health challenges often intersect, understanding the relationship between conditions like colon cancer and shingles becomes crucial for effective management and prevention, especially since both can significantly impact quality of life when they occur simultaneously. This creates a

Cilta-Cel Redefines Myeloma Treatment with Lasting Remission
Research & Development Cilta-Cel Redefines Myeloma Treatment with Lasting Remission

Imagine a world where a single treatment could halt the relentless cycle of relapse in a disease as challenging as multiple myeloma, a blood cancer notorious for its grim prognosis in advanced stages, offering hope to patients who have exhausted standard therapies. For these patients, the outlook

Healthy Habits and GLP-1 Drugs Boost Heart Health in Diabetes
Research & Development Healthy Habits and GLP-1 Drugs Boost Heart Health in Diabetes

What if a simple combination of daily choices and modern medicine could halve the risk of heart attacks for millions living with Type 2 diabetes? Across the United States, where this condition affects over 30 million people, cardiovascular disease remains the leading cause of death for those

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later